Service
Screening compounds and building blocks from stock or made to order.
341–360 of 411 suppliers
Cambridge, United Kingdom · isogenica.com
Isogenica is a contract research organisation in Cambridge, UK that specializes in small-format antibody discovery, especially VHH single-domain antibodies. It supports biotech and pharma partners with discovery, engineering, and candidate progression for therapeutic and diagnostic programs.
Cambridge, United Kingdom · isomerase.com
Isomerase is a synthetic biology company in Cambridge, United Kingdom. It works with biotechnology, pharmaceutical, industrial, consumer product, agritech, chemical manufacturing, and food and ingredients partners to develop microbial, enzyme, peptide, natural product, and small-molecule programs from concept through scale-up and manufacturing readiness.
Brantford, ON, Canada · jsiresearch.ca
JSI Research Chemicals Inc. is a North American research-based company in Brantford, Ontario. It provides custom synthesis, analytical support, drug discovery and development, and related consultancy and laboratory setup services for pharmaceutical and biotechnology clients.

Mumbai, India · lmscdmo.com
Lupin Manufacturing Solutions Limited is a contract development and manufacturing organization and API manufacturer serving biopharma and pharma partners. It provides development and manufacturing support from early-stage work through commercial scale, with services centered on drug substances, drug products, building blocks, intermediates, and specialized modalities. The company is part of Lupin and operates globally.
Morrisville, NC · lucideon.com
Lucideon is a materials science consultancy and testing organization serving clients in industries such as aerospace, ceramics, construction, energy, healthcare and life sciences, and nuclear. It works from facilities in the UK, the US, Japan, and Ireland, providing materials development, process optimization, characterization, testing, and assurance services.
East Princeton, NJ · madescientific.com
Made Scientific is a cell therapy CDMO that supports development through GMP and commercial manufacturing for autologous and allogeneic therapies. It works with cell types including T cells, B cells, NK cells, HSCs, MSCs, iPSCs, TILs, and exosomes, with sites in Princeton, New Jersey and East Norriton, Pennsylvania.

New York, NY · manhattanbiosolutions.com
Manhattan BioSolutions develops precision biologic therapies, with a focus on next-generation antibody-drug conjugates for advanced cancers. It collaborates with academic researchers and other partners and is based in New York City.
Mont-Saint-Guibert, Belgium · minakem.com
Minakem develops and manufactures small molecule APIs and HPAPIs for pharmaceutical companies. It operates production and development sites in France, Belgium, and Canada, serving development through commercial supply.

San Diego, CA · modelmedicines.com
Model Medicines is an AI-first biotechnology company that discovers and develops small-molecule therapeutics. It focuses on preclinical programs targeting biological choke points in viral replication and transcriptional control, including antiviral and oncology-related programs.

Basel, Switzerland · monterosatx.com
Monte Rosa Therapeutics is a biotechnology company developing targeted protein degradation medicines. It operates in Boston, Massachusetts and Basel, Switzerland, with a focus on cardiometabolic, inflammation, immunology, and oncology programs.
Strasbourg, France · novalix.com
Novalix is a contract research organization in drug discovery. It works with biotech firms and pharmaceutical companies from its headquarters near Strasbourg, France, supporting early-stage discovery across chemistry, biophysics, pharmacology, and DMPK.

Concord, OH · olon-usa.com
Olon USA is the U.S. site of Olon, a contract development and manufacturing organization serving pharmaceutical customers. It operates in the United States and is part of the broader Olon organization.

San Francisco, CA · omniox.com
Omniox is an IND-stage biotechnology company in San Francisco, California. It develops H-NOX-based OMX biologics intended to deliver oxygen to hypoxic tissues for diseases where low oxygen levels drive pathology. The company works on oxygen-based therapies using its proprietary platform technology.
Sunderland, United Kingdom · onyxipca.com
Onyx Scientific Limited is a small molecule CDMO that supports process R&D, analytical development, solid state work, and API manufacturing from early development through commercial supply. It serves academic, biotech, pharmaceutical, and other drug-development clients from facilities in Sunderland, UK and North Carolina, US. The company also supports low-volume commercial API manufacturing from its UK site.
Ghent, Belgium · orionisbio.com
Orionis Biosciences is a clinical-stage life sciences company developing precision medicines for cancer. It works from Waltham, Massachusetts and Ghent, Belgium, using discovery platforms for small molecules, cytokine biologics, and cell engagers.

Daejeon, South Korea · orumrx.com
Orum Therapeutics is a biopharmaceutical company that develops antibody-based protein degrader therapeutics for cancer and immune diseases. It is based in South Korea and focuses on combining protein degraders with antibodies to create differentiated drug candidates.

Montpellier, France · oxeltis.com
Oxeltis is a medicinal chemistry and drug discovery CRO based in Montpellier, France. It supports biotech, startup, and technology transfer office clients with integrated chemistry, screening, and early safety work from hit discovery through lead optimization and custom synthesis.

Nanjing, China · pharmablock.com
PharmaBlock provides chemistry products and services across the pharmaceutical R&D process and commercial manufacturing for global pharmaceutical and biotech companies. It operates sites in the USA, China, and Switzerland and serves drug discovery, development, and GMP manufacturing needs.

London, United Kingdom · pharmidex.com
Pharmidex is a contract research organisation in London that supports pharmaceutical, biotechnology, and academic partners with drug discovery, preclinical research, and bioanalytical services. It works across discovery through clinical development and focuses on preclinical studies and regulated sample analysis.

Sovicille, Italy · philogen.com
Philogen is a Swiss-Italian biotechnology company that discovers, manufactures, and develops targeted biopharmaceutical products for cancer and other serious conditions. It operates from sites in Italy and Switzerland, with discovery activities in Zurich, GMP manufacturing near Siena, and clinical operations in Milan. The company was founded in 1996 and is listed on the Italian Stock Exchange.